Prof. Amit Tirosh is a senior endocrinologist and Head of the Neuroendocrine Tumors Service at Sheba Medical Center. He specializes in neuroendocrine tumors (NETs).
His work centers on hereditary NET syndromes. He is affiliated with the NIH in MEN1 research. He serves on an international VHL expert panel and helped write VHL management guidelines. He is the primary contact at Sheba’s multidisciplinary VHL clinic.
He leads the Endocrine Oncology Bioinformatics Lab. He collaborates with international teams, including the Weizmann Institute. He provides advanced NET care, including PRRT.
He earned his MD from the Hebrew University–Hadassah. He completed a residency at Assaf HaRofeh, an endocrinology fellowship at Rabin, and training at the NIH. He is board-certified in Endocrinology. He is a member of the Israeli Society of Endocrinology, the Endocrine Society, and the European Neuroendocrine Tumor Society. He has authored over 40 peer-reviewed papers, including in JAMA, Gastroenterology, and Radiology.
アリ・ラファエル教授――テルアビブ・スラスキー医療センター(イキロフ、テルアビブ)トランスレーショナル腫瘍学部門長および臨床がん研究部門研究員。患者一人ひとりのニーズに寄り添う個別対応のアプローチが高く評価されています。
資格および患者への貢献:
腫瘍科デイホスピタルを統括し、国家ゲノム医療プロジェクトを主導。最先端の研究へのアクセスを提供しています。
主任副研究者および主任研究者として、腫瘍内mRNA投与やウイルス製剤を含むフェーズI〜IIIの多数の臨床試験に携わってきました。患者は革新的な治療法への参加機会を得られます。
米国および英国における国際的な臨床経験を有し、世界水準の治療基準と先進的なプロトコルの適用を保証しています。
国際学術団体の会員(ESMO、IASLC、ISLB、ISCORT、Israeli Medical Association)。最新の治療基準を活用し、国際的な研究に参画しています。
ICH GCP R2、Israeli MOH Guidelinesをはじめ、インフォームドコンセント、副作用管理および患者安全に関する最新課程を含む国際臨床実践基準に基づき、定期的に専門知識の更新および研修を実施しています。
ラファエル教授は、精密な治療レジメンの選択、革新的手法の導入、そして細やかな患者対応により高い信頼を得ており、治療のすべての段階において患者が安心して療養に臨める環境を提供しています。
Israeli specialists provide detailed consultations for international patients seeking radioiodine therapy for thyroid conditions. Leading experts from JCI-accredited centers like Sourasky Medical Center offer both remote and in-person meetings. These sessions include comprehensive medical record reviews and personalized treatment planning for thyroid cancer and hyperthyroidism.
Bookimed Expert Insight: Israeli oncology and endocrinology departments show a strong pattern of US-based training. Several top doctors, including Dr. Ilana Itzhakov and Prof. Amit Tirosh, completed fellowships at institutions like the NIH or UCLA. This international background allows them to apply global radioiodine protocols directly to complex patient cases.
Patient Consensus: Patients note that paying for consultations upfront is mandatory since healthcare coverage does not apply to non-residents. They suggest that those with thyroid cancer often receive faster scheduling for initial meetings. Many found that staff in Tel Aviv and Jerusalem speak English fluently during medical discussions.
Israeli doctors use personalized dosimetry to calculate radioiodine doses based on individual metabolism and anatomy. Specialists like Dr. Orit Gutfeld at Sourasky Medical Center integrate gland weight, radioiodine uptake percentages, and isotope clearance rates. This data-driven approach ensures precise radiation delivery to thyroid tissue while protecting healthy organs.
Bookimed Expert Insight: Israeli specialists often combine genomic profiling with traditional dosimetry to refine treatment for complex cases. Dr. Ari Raphael at Sourasky Medical Center offers consultations for $750 to evaluate personalized cancer treatments. This high level of expertise helps doctors adjust doses for patients with additional clinical risk factors.
Patient Consensus: Patients note the গুরুত্ব of the strict two-week low-iodine diet to improve uptake accuracy. Many were surprised that doctors may use recombinant TSH injections to avoid the symptoms of hypothyroidism. Experience shows that tailored doses are especially vital for those with unique thyroid gland sizes.
Israel offers specialized radioiodine expertise for pediatric patients through dedicated children's hospitals and specialized centers. Leading experts like Dr. Uri Eal provide tailored treatments for pediatric thyroid disorders using protocols refined at top US institutions like Cincinnati Children's Hospital.
Bookimed Expert Insight: Data shows that pediatric thyroid care in Israel is highly centralized in Tel Aviv. Specialists like Dr. Uri Eal and Dr. Asaf Oren at Sourasky Medical Center hold dual academic roles in Israel and North America. This ensures children receive treatments that meet both Israeli and international safety benchmarks. Patients can also obtain an online consultation with oncologists like Dr. Ari Raphael for $750 to discuss treatment plans.
Patient Consensus: Parents note that Israeli hospitals are very proactive regarding long-term health, often suggesting fertility banking before starting therapy. Families emphasize the importance of preparing for the mandatory five to seven day isolation period after treatment. Many were surprised by the strictness of radiation safety rules but felt reassured by the world-class nuclear medicine facilities.